Search Results 711-720 of 24239 for In situ
Researchers at Mayo Clinic are currently studying the use of the fluorescence in situ hybridization (FISH) test in the diagnosis of bile duct cancer in people ...
... in situ of the cervix. Subject who has severe, progressive, or uncontrolled renal, hepatic, hematological, endocrine, disorder or symptoms thereof. Female ...
... in situ cervical cancer, superficial bladder cancer, or high grade intestinal polyps treated adequately, regardless of the disease-free interval. History of ...
Disease worsening in the ... situ (AIS), high-grade squamous intraepithelial ... In the opinion of the investigator, any new (since enrolling in ...
History of malignancy within 5 years prior to screening, with the exception of localized nonmetastatic basal cell carcinoma of the skin and in-situ carcinoma of ...
carcinoma in situ, Male breast cancer, Endometrial cancer, Phyllodes tumor. Show more areas of focus for Oluwadamilola T. Oladeru, M.D., M.B.A. ...
About this study. Fluorescence in situ hybridization (FISH) has improved the diagnostic performance of cytology for evaluation of malignant biliary ...
... in situ cervical cancer that has undergone potentially curative therapy); Has a history of (non-infectious) pneumonitis that required steroids or current ...
... in situ of the cervix. If the Week 12/Week 16 or Week 52 (Study M13-740) ... Enrollment in another interventional clinical study while participating in this study: ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.